A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults

Clinical trial NCT02582632 · COMPLETED

Trial details

NCT number

NCT02582632

Sponsor

AbbVie

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2015-11-24

Primary completion

2016-08-24

Enrollment

166

View on ClinicalTrials.gov